肥胖对慢性鼻窦炎结构化组织病理学的影响
本研究回顾性分析了476例接受功能性内镜鼻窦手术的慢性鼻窦炎患者,按BMI分组比较结构化组织病理学特征。结果发现III级肥胖与增生性/乳头状改变、Charcot-Leyden结晶和鳞状化生显著增加相关,提示III级肥胖患者的CRS可能遵循非2型炎症通路。
要点
- III级肥胖CRS患者增生性/乳头状改变比例显著高于非肥胖者。
- III级肥胖与Charcot-Leyden结晶和鳞状化生增多独立相关。
- III级肥胖CRS可能呈非2型炎症模式,或可预测疾病严重程度。
核心结论
- 多种结构化组织病理学变量在接受功能性内镜鼻窦手术的肥胖患者中显著更常见,可能作为CRS严重程度的预测指标,并提示III级肥胖患者的CRS遵循非2型炎症通路。
研究设计与样本
- 回顾性图表审查纳入476例伴或不伴鼻息肉的慢性鼻窦炎患者,均接受功能性内镜鼻窦手术,收集结构化组织病理学、人口学和合并症数据,采用卡方、逻辑回归和多变量分析。
主要发现
- 队列中女性占53.8%,平均年龄52.01岁,平均BMI 29.74。
- 非肥胖(BMI<30)290例(60.9%),I级肥胖(BMI 30-34.9)100例(21.0%),II级肥胖(BMI 35-39.9)40例(8.4%),III级肥胖(BMI≥40)46例(9.7%)。
- III级肥胖与增生性/乳头状改变(17.4% vs. 5.6%,p<0.026)、Charcot-Leyden结晶(17.4% vs. 6.6%,p<0.037)和鳞状化生(26.1% vs. 17.6%,p<0.028)的显著增加相关。
- 多变量分析控制哮喘、吸烟、CRS亚型和糖尿病状态后,未发现这些变量为混杂因素。
临床怎么用
- 对于III级肥胖的CRS患者,应意识到其组织病理学可能更常见增生性/乳头状改变、Charcot-Leyden结晶和鳞状化生,提示非2型炎症通路,可能影响治疗策略选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Obesity is an established risk factor for asthma, which shares common inflammatory pathways with chronic rhinosinusitis (CRS). However, the link between obesity and CRS remains poorly understood. By identifying trends in the structured histopathology (SHP) of obese patients with CRS, we aim to better understand how changes in the tissue architecture of obese patients may contribute to CRS. METHODS: Retrospective chart review was conducted on 476 patients with CRS with and without nasal polyps who underwent functional endoscopic sinus surgery. Data were collected on SHP, demographics, and comorbidities. Chi-squared, logistic analyses, and multivariate analysis were performed. RESULTS: The patient cohort was 53.8% female. Mean age was 52.01 years and mean BMI was 29.74. A total of 290 (60.9%) patients were nonobese (BMI < 30), 100 (21.0%) were Class I obese (BMI 30-34.9), 40 (8.4%) were Class II obese (BMI 35-39.9), and 46 (9.7%) were Class III obese (BMI ≥ 40). It was found that class III obesity was associated with statistically significant increases in several histopathological markers, including hyperplastic/papillary changes (17.4% vs. 5.6%, p < 0.026), Charcot-Leyden crystals (17.4% vs. 6.6%, p < 0.037), and squamous metaplasia (26.1% vs. 17.6%, p < 0.028). Multivariate analysis was performed, controlling for asthma, smoking, CRS subtype, and diabetes mellitus status. None of the variables were identified as confounders. CONCLUSION: Several SHP variables are significantly more prevalent in obese patients who underwent functional endoscopic sinus surgery. This may serve as a predictor of CRS severity and suggests CRS in Class III obese patients follows a non-type 2 inflammatory pathway. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03816891.
引用
- Ma DX, Neerumalla S, Baird A, et al. Impact of Obesity on the Structured Histopathology of Chronic Rhinosinusitis Patients. Laryngoscope. 2025. PMID: 41051123. doi:10.1002/lary.70177
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。